Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 5/2013

PHARMACOLOGICAL TREATMENT IN STABILIZING THE SYMPTOMS IN CHILDREN WITH ADHD SYMPTOMS

HOUSSEIN TOUFIC SEBLANY1, IULIANA ŞTEFANIA DINU1*, MONICA SAFER2, DOINA ANCA PLEŞCA2

1University of Medicine and Pharmacy „Carol Davila”, 37 Dionisie Lupu street, Bucharest
2Department of Pediatrics and Pediatric Neurology, „Victor Gomoiu” Children Clinical Hospital, University of Medicine and Pharmacy „Carol Davila”, 37 Dionisie Lupu street, Bucharest

Download Full Article PDF

Attention-deficit/hyperactivity disorder (ADHD) is a chronic disorder characterized by problems with paying attention, impulsivity and over-activity which influence all the life fields of a child with ADHD. The prevalence of ADHD in children is approximately 7% worldwide, both males and females being affected and with different etiology. A high rate of these patients present neurologic etiology, determined by factors which occurred in different stages of the development process. The consequences of ADHD cause social problems because these children have difficulties regarding family, school and social integration, associating a considerable impairment in the quality of life (QoL). The goal of therapeutic approaches is to improve the QoL by managing the symptoms. There is no treatment for curing ADHD, but there is a pharmacologic treatment used in order to control the symptoms. The goal of the study was to determine the impact of treatment on symptoms control in ADHD patients. The subjects were administered methylphenidate or atomoxetine. The ADHD symptoms were screened with Child Symptom Inventory-4 scale. Pharmacological treatment and early diagnosis have a positive impact on outcomes, QoL and long-term prognosis.